Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial

Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial

Christian Homsy talked about Celyad on Antipode radio!

Christian Homsy talked about Celyad on Antipode radio!

Celyad retains Piper Jaffray & Co. to explore strategic alternatives relating to its C-Cure® cardiovascular assets

Celyad retains Piper Jaffray & Co. to explore strategic alternatives relating to its C-Cure® cardiovascular assets

Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)

Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)

Discover our news

Upcoming events

Mar 6-8, 2017

Cowen 37th Annual Health Care Conference

Mar 09, 2017

Boston Biotech Conference

Mar 20-24, 2017

CHI Immuno-Oncology Summit

Discover all events

Press contacts

Stern Investor Relations (US)

Will O’Connor, Michael Schaffzin

+1 212 362 1200

Celyad

Marine Lhomel
Corporate Communications Manager

+32 (0)10 39 41 94

Consilium Strategic Communications (UK)

Chris Welsh, Chris Gardner

+44 20 3709 5700

NewCap (France)

Nicolas Merigeau, Pierre Laurent

+ 33(0)1 44 71 94 94

Comfi (Belgium)

Gunther De Backer, Sabine Leclercq

+32(0) 2 290 90 91